Prognostic factors for progression in atypical meningioma
Shakir I. Shakir, Marie‐Christine Guiot(McGill University), Kevin Petrecca(McGill University Health Centre), Luís Souhami(McGill University Health Centre), George Shenouda, Bassam Abdulkarim(University of Alberta), Valérie Panet-Raymond(McGill University Health Centre), Amal A. Al-Odaini(McGill University Health Centre), Khushdeep Singh(Centre for Biomedical Engineering and Physics), José João Mansure(McGill University Health Centre)
Cited by 65
Related Papers
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k